MAPT and tauopathy: We believe that combining these advances with insights into putative natural co-factors and PTMs that regulate Tau aggregation and pathology formation will provide a powerful platform (Fig. 10) to systematically evaluate and screen different combinations of Tau proteins and biochemical conditions and identify conditions that could enable reproducing the structure of pathological Tau aggregates from different Tauopathies (Fig. 10, Applications).